Literature DB >> 10974059

Comparison of deuterium incorporation and mass isotopomer distribution analysis for measurement of human cholesterol biosynthesis.

M Di Buono1, P J Jones, L Beaumier, L J Wykes.   

Abstract

To compare endogenous cholesterol biosynthesis measured by deuterium incorporation (DI) and mass isotopomer distribution analysis (MIDA), cholesterol fractional and absolute synthetic rates were measured simultaneously by both techniques under identical physiological conditions. Twelve subjects (22 to 39 years of age) underwent a dual stable isotope protocol, involving oral deuterium oxide administration and measurement of incorporation of deuterium into cholesterol coincident with constant infusion of sodium [1-(13)C]acetate and measurement of the mass isotopomer distribution pattern of newly synthesized cholesterol. Synthesis was determined over 24 h with a 7-h feeding period. Both methods yielded similar measurements of fractional cholesterol synthesis (7.8 +/- 2.5% day(-)(1) for DI vs. 6.9 +/- 2.2% day(-)(1) for MIDA). Correlation of fractional synthesis across techniques was strong (r = 0.84, P = 0.0007). Absolute synthesis rates were also not different at 24 h (13.4 +/- 4.3 mg kg(-)(1) day(-)(1) for DI vs. 11.9 +/- 3.6 mg kg(-)(1) day(-)(1) for MIDA, r = 0.79, P < 0.002). We conclude that despite different assumptions and analytical requirements, deuterium incorporation and MIDA yield similar rates of cholesterogenesis in humans when measurements are made over 24 h. The decision as to which method to adopt depends on available clinical and analytical facilities

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974059

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Quantifying cholesterol synthesis in vivo using (2)H(2)O: enabling back-to-back studies in the same subject.

Authors:  Stephen F Previs; Ablatt Mahsut; Alison Kulick; Keiana Dunn; Genevieve Andrews-Kelly; Christopher Johnson; Gowri Bhat; Kithsiri Herath; Paul L Miller; Sheng-Ping Wang; Karim Azer; Jing Xu; Douglas G Johns; Brian K Hubbard; Thomas P Roddy
Journal:  J Lipid Res       Date:  2011-04-17       Impact factor: 5.922

2.  Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.

Authors:  Melissa A Babcook; Sanjeev Shukla; Pingfu Fu; Edwin J Vazquez; Michelle A Puchowicz; Joseph P Molter; Christine Z Oak; Gregory T MacLennan; Chris A Flask; Daniel J Lindner; Yvonne Parker; Firouz Daneshgari; Sanjay Gupta
Journal:  Mol Cancer Ther       Date:  2014-08-13       Impact factor: 6.261

3.  The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical species.

Authors:  David G McLaren; Timothy He; Sheng-Ping Wang; Vivienne Mendoza; Raymond Rosa; Karen Gagen; Gowri Bhat; Kithsiri Herath; Paul L Miller; Sloan Stribling; Andrew Taggart; Jason Imbriglio; Jinqi Liu; Dunlu Chen; Shirly Pinto; James M Balkovec; Robert J Devita; Donald J Marsh; Jose M Castro-Perez; Alison Strack; Douglas G Johns; Stephen F Previs; Brian K Hubbard; Thomas P Roddy
Journal:  J Lipid Res       Date:  2011-03-17       Impact factor: 5.922

4.  Isotopomer analysis of lipid biosynthesis by high resolution mass spectrometry and NMR.

Authors:  Andrew N Lane; Teresa W-M Fan; Zhengzhi Xie; Hunter N B Moseley; Richard M Higashi
Journal:  Anal Chim Acta       Date:  2009-08-27       Impact factor: 6.558

5.  The behavioral and clinical effects of therapeutic lifestyle change on middle-aged adults.

Authors:  Steven G Aldana; Roger L Greenlaw; Hans A Diehl; Audrey Salberg; Ray M Merrill; Seiga Ohmine; Camille Thomas
Journal:  Prev Chronic Dis       Date:  2005-12-15       Impact factor: 2.830

6.  NMR Methods for Determining Lipid Turnover via Stable Isotope Resolved Metabolomics.

Authors:  Penghui Lin; Li Dai; Daniel R Crooks; Leonard M Neckers; Richard M Higashi; Teresa W-M Fan; Andrew N Lane
Journal:  Metabolites       Date:  2021-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.